Position in ELAN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,580,088
+$3,025,372 QoQ
Shares Held
316,761
+57.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.36299607590581.ToString("F0")%
Shared 0.ToString("F0")%
None 2.637003924094191.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $156,487,204 across 25 Drug Manufacturers - Specialty & Generic names. ELAN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
358,659 | $42,397,077 | |
| 2 | HLN |
Haleon plc
|
2,181,908 | $21,840,896 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,825,184 | $17,375,751 | |
| 4 | VTRS |
Viatris Inc
|
923,786 | $12,480,347 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
628,550 | $11,640,744 | |
| 6 | HROW |
Harrow, Inc.
|
234,660 | $8,274,111 | |
| 7 | ELAN |
Elanco Animal Health Inc
This page
|
316,761 | $7,580,088 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,595 | $6,252,760 |
All Filings in ELAN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,580,088 | 316,761 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,554,716 | 201,269 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,048,412 | 250,666 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,378,931 | 306,648 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,085,015 | 293,811 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,764,433 | 228,277 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,646,777 | 112,102 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $886,939 | 61,465 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $517,295 | 31,775 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $622,059 | 41,749 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $2,084,489 | 185,453 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,133,147 | 112,639 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $706,963 | 75,209 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $797,560 | 65,267 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,302,353 | 104,944 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,057,025 | 461,387 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,003,124 | 498,395 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,132,188 | 497,963 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,850,176 | 434,311 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,990,996 | 403,315 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,137,808 | 344,238 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $11,517,503 | 375,530 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,244,483 | 259,380 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,070,328 | 236,379 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,024,337 | 224,401 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||